arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Vor Biopharma Inc.

VOR

$23.65 ▼ -0.07 (-0.30%) at close

26 Visible periods

18 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Neutral Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, Vor Biopharma Inc. shows solid but mixed fundamentals, with Return on Invested Capital holding up well. Watch FCF / Net Income against typical quality thresholds. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $1.0B

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 18.5% ↗

FCF / Share $-0.89

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-219.59M

↓ -575.9% —

FCF / Share Free cash flow per share

$-0.89

↓ -255.1% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

Return on Invested CapitalReturn on Invested Capital of 178.7% is excellent on an absolute basis (target > 10%)

warning

Bearish Risks

FCF / Net IncomeFCF / Net Income of 0.21x is weak on an absolute basis (target > 1x)

Health Breakdown

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	-1865.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-30307.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-2963.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	42.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-2210.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	95.9% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	95.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	94.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	96.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	22.2% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	22.4% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	—	-8.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-26.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-16.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-575.9% Weak ↓ Weak Declining Year-over-year change in net income	N/M	-5.5% Weak ↑ Weak Improving Year-over-year change in net income	-5.5% Weak ↑ Weak Improving Year-over-year change in net income	-5.5% Weak ↑ Weak Improving Year-over-year change in net income	-16.9% Weak ↓ Weak Declining Year-over-year change in net income	-8.3% Weak ↑ Weak Improving Year-over-year change in net income	-8.3% Weak ↑ Weak Improving Year-over-year change in net income	-8.3% Weak ↑ Weak Improving Year-over-year change in net income	-9.8% Weak ↑ Weak Improving Year-over-year change in net income	-25.1% Weak ↑ Weak Improving Year-over-year change in net income	-25.1% Weak ↑ Weak Improving Year-over-year change in net income	-25.1% Weak ↑ Weak Improving Year-over-year change in net income	-31.0% Weak ↑ Weak Improving Year-over-year change in net income	-65.7% Weak ↓ Weak Declining Year-over-year change in net income	-65.7% Weak ↓ Weak Declining Year-over-year change in net income	-65.7% Weak ↓ Weak Declining Year-over-year change in net income	-16.5% Weak ↑ Weak Improving Year-over-year change in net income	-74.8% Weak → Weak Stable Year-over-year change in net income	-74.8% Weak Weak Year-over-year change in net income	-74.8% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	-255.1% Weak Weak Year-over-year change in free cash flow	—	—	—	44.2% Excellent Excellent Year-over-year change in free cash flow	—	—	—	93.9% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
FCF / Net Income (x)	0.17x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.01x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.66x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.99x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.10x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.31x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.27x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.37x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.25x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.13x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	18.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	17.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	1.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	14.4% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	-39.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.6% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-30.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	20.9% Excellent → Excellent Stable Return earned on debt + equity capital invested Optimal: > 10%	21.1% Excellent → Excellent Stable Return earned on debt + equity capital invested Optimal: > 10%	19.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	24.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-6.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-15.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-133.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-30.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-24.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-7.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-4.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-20.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	146.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+873%)	—	1.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-90%)	2.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-86%)	-49.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-428%)	-31.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-312%)	-42.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-381%)	-31.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-309%)	-25.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-267%)	-17.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-216%)	-16.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-208%)	-13.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-193%)	-12.4% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-182%)	-9.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-164%)	-14.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-195%)	-13.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-187%)	-11.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-178%)	-8.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-156%)	-5.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-139%)	-5.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	-5.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-134%)	26.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+77%)	17.8% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+19%)	23.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+59%)	31.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+108%)	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Net Debt (USD)	$-169.87M	$-396.49M	$-160.46M	$-190.57M	$-50.05M	$-81.95M	$-52.80M	$-76.08M	$-44.96M	$-31.36M	$-45.03M	$-32.21M	$-42.45M	$-57.71M	$-60.83M	$-62.95M	$-90.04M	$-119.80M	$-143.03M	$-169.52M	$-262.57M	$-48.54M	$-63.60M	$-72.91M	—	—

📊 What does each share earn? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Basic EPS, GAAP (USD)	$-5.11	$307.61	$-121.63	$-12.56	$-0.26	$-8.78	$-0.40	$-0.41	$-0.45	$-0.38	$-9.80	$-9.00	$-8.60	$-10.40	$-12.60	$-11.60	—	$-9.60	$-10.00	$-10.00	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.89	—	$-8.07	$-0.28	$-0.25	—	—	—	$-0.45	—	—	—	$-7.35	—	—	—	—	—	$-9.74	$-9.49	—	—	—	—	—	—
Book Value per Share (USD)	$-2.78	$-4.24	$-246.54	$-11.98	$0.53	$15.49	$1.06	$1.43	$1.80	$2.22	$51.57	$60.64	$68.79	$75.95	$82.69	$93.30	$104.16	$116.35	$126.15	$135.77	$145.33	$-2.34K	—	—	—	—
Tangible Book Value per Share (USD)	$-2.78	$-4.24	$-246.54	$-11.98	$0.53	$15.49	$1.06	$1.43	$1.80	$2.22	$51.57	$60.64	$68.79	$75.95	$82.69	$93.30	$104.16	$116.35	$126.15	$135.77	$145.33	$-2.34K	—	—	—	—
Basic Weighted Avg Shares (shares)	43.01M	—	6.68M	125.27M	124.82M	—	68.47M	68.30M	68.03M	—	3.38M	3.35M	3.31M	—	1.90M	1.87M	—	—	1.85M	1.84M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$484.70M	$432.93M	$153.65M	$146.15M	$48.12M	$77.89M	$52.95M	$76.45M	$98.60M	$125.23M	$149.05M	$178.68M	$204.32M	$223.83M	$131.63M	$146.58M	$172.16M	$204.25M	—	—	$257.63M	$38.90M	—	—	—	—
Total Equity (USD)	$-150.42M	$-164.31M	$-2.23B	$-1.51B	$66.07M	$96.66M	$72.95M	$98.08M	$123.03M	$150.72M	$174.78M	$204.45M	$230.22M	$250.61M	$158.73M	$174.97M	$194.45M	$216.26M	$232.96M	$250.11M	$267.19M	$-59.06M	$-44.14M	$-32.99M	$-25.12M	$-17.43M

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Depreciation Expense (USD)	$28.00K	$23.00K	$2.00K	$2.10M	$825.00K	$865.00K	$900.00K	$900.00K	$943.00K	$892.00K	$900.00K	$900.00K	$837.00K	$632.00K	$900.00K	$600.00K	$426.00K	$395.00K	$300.00K	$400.00K	$311.00K	$242.00K	$200.00K	$100.00K	$66.00K	—
Net Income, GAAP (USD)	$-219.59M	$1.72B	$-32.49M	$-32.49M	$-32.49M	$-30.71M	$-30.80M	$-30.80M	$-30.80M	$-26.26M	$-28.43M	$-28.43M	$-28.43M	$-23.91M	$-22.74M	$-22.74M	$-22.74M	$-18.25M	$-13.72M	$-13.72M	$-13.72M	$-15.66M	$-7.85M	$-7.85M	$-7.85M	—
Operating Cash Flow (USD)	$-38.25M	$-22.80M	$-53.66M	$-35.18M	$-31.07M	$-24.06M	—	—	$-30.46M	$-24.03M	—	—	$-24.27M	$-18.35M	—	—	$-22.90M	$-17.59M	$-17.34M	$-16.57M	$-17.65M	$-13.63M	$-8.24M	$-8.33M	$-6.08M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

Vor Biopharma Inc.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare VOR with peers